Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication
- 29 October 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (6) , 102326
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Physiology of gangliosides and the role of antiganglioside antibodies in human diseasesCellular & Molecular Immunology, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective studyNeuropsychiatric Disease and Treatment, 2019
- Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosisNature Reviews Neurology, 2014
- Early recognition of poor prognosis in Guillain-Barré syndromeNeurology, 2011
- Guillain-Barré syndrome: An updateJournal of Clinical Neuroscience, 2009
- Cerebrospinal fluid biomarkers in Guillain-Barré syndrome – Where do we stand?Journal of Neurology, 2009
- Guillain-Barré syndromeThe Lancet, 2005
- Acute motor axonal neuropathy and acute motor-sensory axonal neuropathy share a common immunological profileJournal of the Neurological Sciences, 1999
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990